Children 0-19 years of age requiring hospitalization with fever for three days or more and two of the following:
a) Acute gastrointestinal symptoms (abdominal pain, vomiting, diarrhea);
b) Rash or bilateral non-purulent conjunctivitis or muco-cutaneous inflammation signs (oral, hands or feet);
c) Hypotension or shock;
d) Features of myocardial dysfunction or pericarditis or valvulitis or coronary abnormalities: ECHO
findings or elevated troponin/ brain natriuretic peptide (BNP)/ natriuretic peptide tests (NT-proBNP);
e) Evidence of coagulopathy: Abnormal prothrombin time/ partial thromboplastin time (PT/PTT), elevated d-dimer;
Elevated markers of inflammation such as erythrocyte sedimentation rate, C-reactive protein, or procalcitonin;
No other obvious microbial cause of inflammation, including bacterial sepsis, staphylococcal or streptococcal shock syndromes, and no alternative plausible obvious diagnosis;
Evidence of SARS-CoV-2 infection (positive NAAT test, antigen test and/or serology) or close contact1 with a confirmed or probable (lab-probable or epi-link probable) COVID-19 case2
1 Close contacts include individuals who lived with or had close contact (within two metres) with a COVID-19
case for more than 15 minutes up to 48 hours prior to symptom onset. Refer to the BCCDC for a full definition of close contacts.
2 Refer to the BCCDC for further information on confirmed and lab-probable COVID-19 cases.